James E. Fickenscher
2019 - Zynerba Pharmaceuticals
In 2019, James E. Fickenscher earned a total compensation of $824.1K as Chief Financial Officer and Vice President, Corporate Development at Zynerba Pharmaceuticals, a 25% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $158,347 |
---|---|
Option Awards | $227,487 |
Salary | $390,411 |
Other | $47,862 |
Total | $824,107 |
Fickenscher received $390.4K in salary, accounting for 47% of the total pay in 2019.
Fickenscher also received $158.3K in non-equity incentive plan, $227.5K in option awards and $47.9K in other compensation.
Rankings
In 2019, James E. Fickenscher's compensation ranked 10,093rd out of 13,971 executives tracked by ExecPay. In other words, Fickenscher earned more than 27.8% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 10,093 | 28th |
Manufacturing | 4,079 | 29th |
Chemicals And Allied Products | 1,549 | 30th |
Drugs | 1,327 | 30th |
Pharmaceutical Preparations | 988 | 29th |
Fickenscher's colleagues
We found two more compensation records of executives who worked with James E. Fickenscher at Zynerba Pharmaceuticals in 2019.
News
Zynerba Pharmaceuticals CEO Armando Anido's 2022 pay slips 15% to $1.9M
April 21, 2023
Zynerba Pharmaceuticals CEO Armando Anido's 2021 pay jumps 49% to $2.2M
April 25, 2022
Zynerba Pharmaceuticals CEO Armando Anido's 2020 pay rises 8% to $1.5M
April 21, 2021
Zynerba Pharmaceuticals CEO Armando Anido's 2019 pay falls 32% to $1.4M
April 23, 2020
Zynerba Pharmaceuticals CEO Armando Anido's 2018 pay slips 18% to $2M
April 25, 2019